← All stocks

Metagenomi Therapeutics, Inc.

MGX Net buying

CIK 0001785279 #4736 in the set updated 17 Sep 2026

Bought (1 mo)

$23.40K

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$5.11K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$5.11K

3 of 3 sales

Net

+$18.29K

+$18.29K against sales at will

By person

6 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Reid Laurence

Director

$23.40K (2)

—

+$23.40K

20,000

0.0529%

$23.60K

—

Irish Jian

See Remarks

—

$2.48K (1)

−$2.48K

668,106

1.77%

$788.37K

+12.1%

Wapnick Pamela

Chief Financial Officer

—

$2.21K (1)

−$2.21K

206,580

0.5468%

$243.76K

+227.6%

Wein Matthew

See Remarks

—

$414.71 (1)

−$414.71

126,133

0.3339%

$148.84K

+762.0%

Thomas Brian C.

Director

—

2,510,960

6.65%

$2.96M

+0.6%

Noonberg Sarah B.

Chief Medical Officer

—

109,135

0.2889%

$128.78K

+8.7%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 4

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 0

History held since 14 Feb 2024